Aurora kinase blockade drives de novo addiction of cervical squamous cell carcinoma to druggable EGFR signalling. Komatsu M, Nakamura K, Takeda T, Chiwaki F, et al. Oncogene 2022;41:2326-2339.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Komatsu M, Nakamura K, Takeda T, Chiwaki F, et al. Aurora kinase blockade drives de novo addiction of cervical squamous cell carcinoma to druggable EGFR signalling. Oncogene 2022;41:2326-2339.
PMID: 35250028